INTRODUCTION
Total hip and knee arthroplasties are among to the most effective, routine, and successful orthopaedic procedures today 9, 28 . Nevertheless, complications do arise. These can result in prosthetic failure and poor long-term patient outcomes. Among possible complications, prosthetic joint infection (PJI) is one of the most difficult and serious conditions to diagnose and manage 11, 14 . Between 1 % and 5 % of all primary total hip and knee arthroplasties are complicated by PJI, and the percentage is even higher after revision procedures 22 . The majority of PJIs are biofilm-dependent, but certain highly virulent bacterial strains do not rely on this strategy and can be detected very early in the course of infection 22 .
In both acute and chronic PJI, Staphylococcus aureus and coagulase-negative staphylococci are regularly isolated. Additionally, there are also some inconspicuous S. aureus strains (the so-called "small colony variants") that can present a complex diagnostic puzzle, mimicking other microorganisms with low virulence like Staphylococcus epidermidis 26 .
Two general schemes of PJI pathogenesis are generally accepted. The first is postoperative colonization of the joint space (hematogenous type) that is more typical for late infections. The second arises via intraoperative colonization (surgical type) that usually manifests days to months postoperatively 21 . If bacteria fail to settle in the joint during this time, the risk of joint sepsis rapidly decreases 8 . From both scenarios it is clear that active prevention of intraoperative and postoperative bacterial colonization is strongly worth the effort.
Several approaches have been proposed to prevent and treat early surgery-related bacterial colonization of prosthetic surfaces. One is the antimicrobial approach that relies on the local release of loaded antibiotics from polymethylmethacrylate (PMMA) bone cement and maintains a sufficient bactericidal concentration in the immediate vicinity for a duration of time after polymerization 15, 20, 27 . Our current study examines the ability of gentamicin-vancomycin loaded PMMA to prevent growth of staphylococci in vitro.
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MATERIALS AND METHODS
Four different biomaterial formulations were prepared to test the ability of staphylococcal growth. The first material (I) manually prepared from original ultrahigh molecular weight polyethylene (UHMWPE) cups (Chirulen, Aesculap, B-Braun, Germany) to obtain slides approximately 1 by 1 cm. The second tested material (II) was PMMA without antibiotics (Palamed ® , 40g, Biomet Merck GmbH, CH-6460, Altdorf) that was prepared to have a similar shape and size as the UHMWPE slides and served as a control. The third (III) and fourth (IV) materials were prepared from Palamed ® G (40 g, Biomet Merck GmbH, CH-3216, Ried b.Kerzers) with the same dimensions as mentioned above. In addition, the fourth sample was loaded with 1 g of vancomycin (Eli Lilly) per batch of Palamed bone cement. The polymer and vancomycin in crystalline form were hand mixed before the monomer was added. The gentamicin-vancomycin antibiotic combination was selected because of the routine high-dose application at our clinic in therapeutic interventions as well as the proven effectiveness from the current literature 4 .
Staphylococcal Isolation and Identification
Four staphylococcal strains were isolated from the patients hospitalized at the Teaching Hospital in Olomouc, Czech Republic (Table 1 
Antibiotic Susceptibility Testing
Antibiotic susceptibility was established for each staphylococcal strain via a standard dilution micromethod 1 . S. aureus reference strains (ATCC 29213 and ATCC 25923) were used for protocol quality control. The isolates were additionally tested for the presence of penicillin binding protein 2a (PBP2a) by a latex agglutination test (MRSA-Screen test, Denka Seiken Co.).
Biofilm Detection
The ability of staphylococci to organize into biofilms was demonstrated by a modified test using crystal violet stain 6 . Isolated staphylococci were cultivated for 24 h in Brain Heart Infusion (BHI, Oxoid) broth containing 0.25 % glucose in microtitration plate wells. After incubation, the BHI broth containing free planktonic cells was drained. Each well was then stained with 1 % crystal violet, rinsed with distilled water, dried, and visually evaluated for the presence of biofilm.
Biomaterial Bacterial Inoculation and Incubation
Each prepared orthopaedic sample was tested against each of the four bacterial isolates (Table 1) in quadruplicate (four identical samples per single material per bacterial isolate). Samples were separately and aseptically placed in a test tube containing 10 ml of BHI broth and inoculated with five colonies of a given staphylococcal isolate. The samples were then incubated under aerobic conditions for 48 h at 37 °C. Evidence of staphylococcal growth was evaluated at 24 and 48 h according to gross visual media opacity and by bacterial cultivation on blood agar (Oxoid) for 24 h at 37 °C under aerobic conditions. The cultivated strains were compared with the original inoculating strains using the methods previously mentioned and DNA analysis.
After 48 h of incubation, the tested materials were removed from their respective test tubes and individually preserved in a dry test tube under sterile conditions for 7 days at room temperature. Following this period, the materials were once again placed in a test tube with 10 ml of BHI broth and incubated for 48 h at 37 °C. After 24 and 48 h, cultivated strains were evaluated using the same methods as before.
DNA Analysis
Staphylococci were also characterized by isolated restriction splitting DNA analysis using Sma I restriction endonucleases (Roche Diagnostics) and pulse field gel electrophoresis (PFGE) splitting. Restriction maps for single isolates were subsequently determined and used for strain comparison.
Isolation of staphylococcal DNA was performed using the established procedures 18, 24 . PFGE was prepared in a 1.2 % agarose gel in a 1 × TBE buffer. Blocks containing restriction enzyme cleaved bacterial DNA were placed in prepared wells in the gel and covered with 0.8 % low melting point agarose. PFGE was run at 5.0 V/cm for 28 h at a pulse time of 0.1 to 30 seconds. The gel was subsequently stained with etidium bromide solution (1 µg/ml) and visualized.
Scanning electron microscopy
Test materials were placed in a fixation solution containing 2 % glutaraldehyde, 1 % formaldehyde, and 0.1 M phosphate buffer at pH 7.2 for two hours. This was followed by a standard SEM (scanning electron microscopy) sample preparation. A single operator (RN) examined all preparations using the scanning electron microscope TESLA BS 340 (Czech Republic) under 3600 ×, and 7000 × magnification.
RESULTS
The results are presented in Table 2 . Before and after the 7 day sterile preservation of the tested materials, the BHI broths containing material IV were visually clear and proved to be sterile after attempting bacterial cultivation on blood agar. The BHI broths containing samples I and II were visually cloudy before and after 7 day sterile preservation and subsequent incubation, and had staphylococcal concentrations higher than 1×10 6 cfu/ml. BHI broths from samples I (UHMWPE) and II (Palamed ® ) allowed staphylococcal growth to the above-mentioned concentrations after only 24 h of incubation. On sample In vitro testing of gentamicin-vancomycin loaded bone cement to prevent prosthetic joint infection III (Palamed ® G), only methicillin-resistant S. aureus (MRSA) strains reached 1×10 6 cfu/ml in 24 h, in contrast to methicillin-sensitive S. aureus and S. epidermidis strains that required 48 h to achieve this concentration under the same conditions. Seven days after removal of the biomaterials from the BHI broths and sterile preservation, reincubation in BHI broth for 48 h demonstrated similar findings. Staphylococcal identification after reincubation showed comparable microbial characteristics when evaluated against previous isolates from the respective orthopaedic materials with positive bacterial growth. Testing of minimal inhibitory concentrations (MIC) to antibiotics further confirmed this finding.
Retrospective identification and comparison of strains via DNA genome analysis was also used to identify and assess each staphylococcal isolate from the tested orthopaedic materials. PFGE demonstrated a very high probability that all retrieved staphylococci were identical to those initially inoculated on respective material formulations. 
-No bacterial particles observed in any fields + Less than 10 bacteria per field + + 10 to 50 bacterial particles per field + + + More than 50 bacterial particles per field SEM showed that the material with gentamicin-vancomycin (IV sample) was effectively protected from bacterial colonization in contrast to the commercially manufactured PMMA and surfaces without antibiotic protection (Fig. 1) . These results were also confirmed by semi-quantitative evaluation of each sample (Table 3) .
DISCUSSION
The ability of coagulase-negative staphylococci to colonize indwelling medical devices has been recognized for some time 26 . It has been shown that key to preventing PJI is to avert bacterial adherence 7 . Measures directed towards this goal include a strict sterile operating room regime, precise surgical technique, patient standardization, local and systemic prophylactic antibiotic administration and others 2 . In general, if bacteria are able to defeat these measures and are given a window of opportunity to invade and establish themselves intraarticularly, PJI may develop or persist.
The exact mechanism by which antibiotics are released from bone cement is unknown to date. However, surface elution and diffusion have been suggested to explain the mechanism of antibiotic liberation from the loaded material 4, 15, 23 . The amount of antibiotic eluted to the surroundings is a function of cement composition, porosity (the higher the better), total surface area exposed to fluid, as well as the concentration (low-versus high-dose) and characteristics of the antibiotic present in the cement 15, 23 . The antibiotic release profile from bone cement is strongly time-dependent with rapid rise during the first 24 h (burst 13 . With the help of a bacterial adhesion assay and modified Kirby-Bauer technique, they concluded that gentamicin-clindamycin loaded bone cement (Genta-Clinda, Merck, Germany) gave the best protection against bacterial colonization.
Gentamicin-vancomycin loaded cements have also been widely evaluated 4 . Both antibiotics are active against most gram-positive organisms. However, gentamicin lacks complete coverage against one-third of MRSA isolates 12 , and according to our experience, can be totally ineffective. This possibly explains the observed growth of MRSA on the surfaces of commercially produced gentamicin bone cement in our study. The gentamicin "microbial gap" is further confirmed by Tunney et al. who tested several antibiotics in vitro against 49 bacterial isolates obtained from orthopaedic implants and found vancomycin and ciprofloxacin to have better coverage than gentamicin 25 . There are several weaknesses in our study. First, the limited number of bacterial strains which were tested decreases the practical relevance of our results. Second, we must take into consideration that in vitro conditions do not precisely idealize the joint environment, since under in vivo conditions, diffusion gradients vary, and there is fluid flow that could significantly decrease the local antibiotic concentrations. Third, the risk for antibiotic loaded PMMA to induce vancomycin and other antibiotic resistant staphylococci was not investigated. Fourth, we did not examine the resulting mechanical strength of PMMA after incorporation of non-structural antibiotic molecules. However, in accordance with other authors 3, 5 , we assume that the addition of 1 g of antibiotic powder insignificantly changes the intrinsic strength of PMMA.
Our study showed that low-dose gentamicin-vancomycin loaded bone cement had an excellent protective effect against staphylococcal colonization of PMMA surfaces in vitro. Although these findings cannot be immediately applied in practice, we do believe that the antibacterial and protective effects of low-dose gentamicin-vancomycin loaded PMMA and other antibiotic combinations warrant further investigation in vivo. From this point of view, it seems reasonable to use any empirically proven low-dose antibiotic combination as an additive to PMMA in highrisk PJI patients.
